JAKARTA/BEIJING: China’s Sinovac Biotech launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma. Separately, Sinovac released details on Monday from a mid-stage, or Phase 2, study in which it said the vaccine candidate appeared to be safe …
Read More »China’s Sinovac releases details of mid-stage trial of COVID-19 vaccine
August 11, 2020